All posts by: Michael Zand

About Michael Zand

Why CRISPR Therapeutics AG Stock Is Rising Today – Madison.com

Continue reading

2018-01-05 NEWS

Madison.com

Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com
CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking
Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool
CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release)
Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release)
The Ledger Gazette –Nasdaq –Post Analyst
all 72 news articles »
Continue reading

2018-01-05 NEWS

Madison.com

Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com
CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking
Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool
CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release)
Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release)
The Ledger Gazette –Nasdaq –Post Analyst
all 72 news articles »
Continue reading

2018-01-05 NEWS

Myeloma Research News

Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
Myeloma Research News
CART cell therapies are based on the genetic manipulation of a patient’s own T-cells. This reprogramming is designed to make the T-cells specific to certain cancer proteins, making them more efficient at eliminating tumors. For multiple myeloma

Continue reading

2018-01-05 NEWS

CNBC

Caltech breakthrough: Bacteria engineered with ‘sonar’ can track, fight disease
CNBC
New treatments like immunotherapy and probiotics can send microbe-sized fighters deep inside the body to fight illness and inflammation that has been linked to disease, but there’s a problem — they are being sent into places we can’t see

Continue reading

2018-01-05 NEWS

Nasdaq

Why CRISPR Therapeutics AG Stock Is Rising Today
Motley Fool
Specifically, the company announced a underwritten public offering of 5,000,000 of its common shares at a public offering price of $22.75 per share before the start of today’s session. Under normal circumstances, a secondary offering that equates to a
CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release)
Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) StockThe Ledger Gazette
CRISPR Therapeutics Announces Proposed Public Offering of Common SharesNasdaq
CNA Finance (press release) –Post Analyst –Simply Wall St
all 69 news articles »
Continue reading

2018-01-05 NEWS

Nasdaq

Why CRISPR Therapeutics AG Stock Is Rising Today
Motley Fool
Specifically, the company announced a underwritten public offering of 5,000,000 of its common shares at a public offering price of $22.75 per share before the start of today’s session. Under normal circumstances, a secondary offering that equates to a
CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release)
Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) StockThe Ledger Gazette
CRISPR Therapeutics Announces Proposed Public Offering of Common SharesNasdaq
CNA Finance (press release) –Post Analyst –Simply Wall St
all 69 news articles »